title: The swinging pendulum of biomarkers in mitochondrial disease: The role of FGF21.
authors: From the Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine (H.E.S., R.H.) and Institute of Neuroscience (R.W.T.), Newcastle University, Newcastle upon Tyne; and John Walton Muscular Dystrophy Research Centre (H.E.S., R.H.), Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, UK.
authors: Hannah E
authors: HE
authors: Steele
authors: From the Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine (H.E.S., R.H.) and Institute of Neuroscience (R.W.T.), Newcastle University, Newcastle upon Tyne; and John Walton Muscular Dystrophy Research Centre (H.E.S., R.H.), Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, UK. rita.horvath@ncl.ac.uk.
authors: Rita
authors: R
authors: Horvath
authors: From the Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine (H.E.S., R.H.) and Institute of Neuroscience (R.W.T.), Newcastle University, Newcastle upon Tyne; and John Walton Muscular Dystrophy Research Centre (H.E.S., R.H.), Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, UK.
authors: Robert W
authors: RW
authors: Taylor
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D005346:Fibroblast Growth Factors / Q000235:genetics* / Q000378:metabolism*; D006801:Humans; D028361:Mitochondrial Diseases / Q000235:genetics*; D009154:Mutation / Q000235:genetics*
chemical_list: D015415:Biomarkers; C414620:fibroblast growth factor 21; D005346:Fibroblast Growth Factors